Generic placeholder image

Current Nanomaterials

Editor-in-Chief

ISSN (Print): 2405-4615
ISSN (Online): 2405-4623

Review Article

Development, Characterization and Evaluation of Nanoemulgel Used for the Treatment of Skin Disorders

Author(s): Sasmita Padhy*, Biswa M. Sahoo*, Bera V.V.R. Kumar and Chinam N. Patra

Volume 6, Issue 1, 2021

Published on: 16 November, 2020

Page: [43 - 57] Pages: 15

DOI: 10.2174/2405461505999201116212037

Price: $65

Abstract

The outer layer of skin and underlying soft layer of tissues have been infected by several infections locally. Infection on local tissue can be overcome by the administration of various topical formulations such as nanoemulgel, niosomal gel, liposomal gel, etc. For obtaining the significant effect of drug delivery, nanoemulgel exhibits a high intensity of activity locally. Emulsion with uniform and extremely small droplet size in the range of 20-200 nm is referred to as nanoemulsion. The emulsion may be oil-in-water or water-in-oil type. This system can improve the permeation of drug substances through the skin. Nanoemulsion is incorporated into a gel base to form Nanoemulgel and can improve the permeation of drug substances through the skin. Nanoemulgel acts as a promising carrier of an intense amount of permitted drugs to produce their effect topically. Efficient adhesion property and immense solubilising of the drug in oil or water phase lead to a larger concentration gradient towards the skin that further increases the penetration of drug substances through the skin. This study provides useful insights into the utilisation of nanoemulgel to provide a better and effective drug delivery tool for the topical system.

Keywords: Nanoemulsion, nanotechnology, heterogeneous, homogenization, cutaneous, infection.

Graphical Abstract
[1]
Elbendary A, Valdebran M, Blattner CM. Common and dangerous skin infections. Curr Dermatol Rep 2016; 5(1): 30-41.
[http://dx.doi.org/10.1007/s13671-016-0128-7]
[2]
McAdam AJ, Sharpe AH. Infectious diseases-bacterial infections Robbins & Cotran pathologic basis of disease. Philadelphia: Elsevier Inc 2005; pp. 371-96.
[3]
Rebora A. Life-threatening cutaneous viral diseases. Clin Dermatol 2005; 23(2): 157-63.
[http://dx.doi.org/10.1016/j.clindermatol.2004.06.020] [PMID: 15802209]
[4]
Swartz MN. Clinical practice. Cellulitis. N Engl J Med 2004; 350(9): 904-12.
[http://dx.doi.org/10.1056/NEJMcp031807] [PMID: 14985488]
[5]
Russo A, Concia E, Cristini F, et al. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin Microbiol Infect 2016; 22(2)(Suppl. 2): S27-36.
[http://dx.doi.org/10.1016/S1198-743X(16)30095-7] [PMID: 27125562]
[6]
Sobel JD. For the mycoses study group. Infectious diseases society of America. Practice guidelines for the treatment of fungal infections. Clin Infect Dis 2000; 30(4): 652.
[http://dx.doi.org/10.1086/313746] [PMID: 10770725]
[7]
Esposito S, Leone S, Petta E, Noviello S, Iori I. Skin and soft tissue infections: classification and epidemiology. Infez Med 2009; 17(Suppl. 4): 6-17.
[PMID: 20428017]
[8]
Ahmad J, Gautam A, Komath S, Bano M, Garg A, Jain K. Topical nano-emulgel for skin disorders: formulation approach and characterization. Recent Pat Antiinfect Drug Discov 2019; 14(1): 36-48.
[http://dx.doi.org/10.2174/1574891X14666181129115213] [PMID: 30488798]
[9]
Bhowmik D, Gopinath D, Kumar BP. Controlled release drug delivery systems Pharma Innov. 2012; 1(10): 25-32.
[10]
DeLouise LA. Applications of nanotechnology in dermatology. J Invest Dermatol 2012; 132(3 Pt 2): 964-75.
[http://dx.doi.org/10.1038/jid.2011.425] [PMID: 22217738]
[11]
Chellapa P, Mohamed AT, Keleb EI. Nanoemulsion and nanoemulgel as a topical formulation. IOSR J of Pharmacy 2015; 5(10): 43-7.
[12]
Bhat NH, Moin A, Gowda DV. Nanotechnology based approaches for transdermal drug delivery. World J of Pharmac Res 2016; 5(3): 1871-87.
[13]
Ananya KV, Preethi S, Patil AB. Recent review on nano sponge. Int J of Res in Pharm Sci 2020; 11(1): 1085-96.
[http://dx.doi.org/10.26452/ijrps.v11i1.1940]
[14]
Kumar A, Subhabrata R, Mahfoozur R. Nano-emulgel: emerging as a smarter topical lipidic emulsion-based nanocarrier for skin healthcare applications. Recent Pat Anti-Infect Drug Disc 2019; 14(1): 1-14.
[15]
Dhibar M, Chakraborty S, Khandai M. Loaded in-situ nanoemulgel: an unique dosage form for ophthalmic drug delivery. Int J Pharm Sci Rev Res 2018; 1(28): 141-7.
[16]
Khan MW, Ahsan MJ, Gupta SK. Development and in-vitro characterization of mucoadhesive nanoemulgel (MNEG) for enhanced delivery of carbamazepine. Int J Adv Pharm Med Bioallied Sci 2017; 132: 1-9.
[17]
Sharif Makhmalzadeh B, Torabi S, Azarpanah A. Optimization of ibuprofen delivery through rat skin from traditional and novel nanoemulsion formulations. Iran J Pharm Res 2012; 11(1): 47-58.
[PMID: 25317184]
[18]
Ghai I, Chaudhary H, Ghai S. A Review of transdermal drug delivery using nano-vesicular carriers: transfersomes. Recent Pat Nanomed 2012; 2: 164-71.
[http://dx.doi.org/10.2174/1877912311202020164]
[19]
Solomon M, D’Souza GG. Recent progress in the therapeutic applications of nanotechnology. Curr Opin Pediatr 2011; 23(2): 215-20.
[http://dx.doi.org/10.1097/MOP.0b013e32834456a5] [PMID: 21412081]
[20]
Paul AJ, Kolarsick BS, Kolarsick MA. Anatomy and physiology of the skin diseases of the skin. In: Habif TP, Ed. Clinical Dermatology. 10th ed. Netherlands: Elsevier 2006; pp. 1-12.
[21]
Gilaberte Y, Prieto-Torres L, Pastushenko I. Anatomy and function of the skin. In: Hamblin M, Avci P, Prow T, Eds. Nanoscience in dermatology. Netherlands: Elsevier Inc 2016; pp. 1-14.
[22]
Esposito S, Bassetti M, Concia E. Diagnosis and management of skin and soft-tissue infections (SSTI). J Chemother 2017; 1973-9478.
[23]
Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol 2008; 19(2): 173-84.
[http://dx.doi.org/10.1155/2008/846453] [PMID: 19352449]
[24]
Esposito S, Noviello S, Leone S. Epidemiology and microbiology of skin and soft tissue infections. Curr Opin Infect Dis 2016; 29(2): 109-15.
[http://dx.doi.org/10.1097/QCO.0000000000000239] [PMID: 26779772]
[25]
Napierkowski D. Uncovering common bacterial skin infections. Nurse Pract 2013; 38(3): 30-7.
[http://dx.doi.org/10.1097/01.NPR.0000426410.39605.a5] [PMID: 23361375]
[26]
Templer SJ, Brito MO. Bacterial skin and soft tissue infections. Hosp Physician 2009; 26: 9-16.
[27]
Bharat P, Atul K, Ajay C. Formulation and evaluation of gel containing miconazole nitrate an antifungal agent. Int J Pharma Res Rev 2013; 2(6): 18-28.
[28]
Kelly BP. Superficial fungal infections. Pediatr Rev 2012; 33(4): e22-37.
[http://dx.doi.org/10.1542/pir.33-4-e22] [PMID: 22474120]
[29]
Cohen FS. How Viruses invade cells. Biophys J 2016; 110(5): 1028-32.
[http://dx.doi.org/10.1016/j.bpj.2016.02.006] [PMID: 26958878]
[30]
Ramdass P, Mullick S, Farber HF. Viral skin diseases. Prim Care 2015; 42(4): 517-67.
[http://dx.doi.org/10.1016/j.pop.2015.08.006] [PMID: 26612372]
[31]
Aly R. Microbial infections of skin and nails. 4th ed. In: Baron S. Medical microbiology United States: the University of Texas Medical Branch at Galveston 1996.
[32]
Feldmeier H, Heukelbach J. Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues. Bull World Health Organ 2009; 87(2): 152-9.
[PMID: 19274368]
[33]
Norgan AP, Pritt BS. Parasitic infections of the skin and subcutaneous tissues. Adv Anat Pathol 2018; 25(2): 106-23.
[PMID: 29351090]
[34]
File TM Jr, Tan JS. Treatment of bacterial skin and soft tissue infections. Surg Gynecol Obstet 1991; 172(Suppl.): 17-24.
[PMID: 2024222]
[35]
Park KC, Han WS. Viral skin infections: diagnosis and treatment considerations. Drugs 2002; 62(3): 479-90.
[http://dx.doi.org/10.2165/00003495-200262030-00005] [PMID: 11827561]
[36]
Salmon N, Fuller C. Fungal skin infections: current approaches to management. Prescriber 2013; 24(8): 31-7.
[http://dx.doi.org/10.1002/psb.1046]
[37]
Ajazuddin AA, Alexander A, Khichariya A, et al. Recent expansions in an emergent novel drug delivery technology: emulgel. J Control Release 2013; 171(2): 122-32.
[http://dx.doi.org/10.1016/j.jconrel.2013.06.030] [PMID: 23831051]
[38]
Schroeter A, Engelbrecht T, Neubert RHH, Goebel AS. New nanosized technologies for dermal and transdermal drug delivery, a review. J Biomed Nanotechnol 2010; 6(5): 511-28.
[http://dx.doi.org/10.1166/jbn.2010.1149] [PMID: 21329045]
[39]
Kale SN, Deore SL. Micro-emulsion and nano emulsion. Sys Rev Pharm 2017; 8(1): 39-47.
[http://dx.doi.org/10.5530/srp.2017.1.8]
[40]
Pund S, Pawar S, Gangurde S. Transcutaneous delivery of leflunomide nanoemulgel: Mechanistic 3 investigation into physicomechanical characteristics, in vitro 4 Q1 anti-psoriatic and anti-melanoma activity. Int J Pharm 2015; 1(2): 148-56.
[41]
Kumar D, Singh J, Antil M, Kumar V. Emulgel-novel topical drug delivery system-a comprehensive review. Int J Pharm Sci Res 2016; 7(12): 4733-42.
[42]
Khurana S, Jain NK, Bedi PMS. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci 2013; 92(6-7): 383-92.
[http://dx.doi.org/10.1016/j.lfs.2013.01.005] [PMID: 23353874]
[43]
Sungpud C, Panpipat W, Chaijan M, Sae Yoon A. Techno-biofunctionality of mangostin extract-loaded virgin coconut oil nanoemulsion and nanoemulgel. PLoS One 2020; 15(1): e0227979.
[http://dx.doi.org/10.1371/journal.pone.0227979] [PMID: 31995599]
[44]
Sugumar S, Clarke SK, Nirmala MJ, Tyagi BK, Mukherjee A, Chandrasekaran N. Nanoemulsion of eucalyptus oil and its larvicidal activity against Culex quinquefasciatus. Bull Entomol Res 2014; 104(3): 393-402.
[http://dx.doi.org/10.1017/S0007485313000710] [PMID: 24401169]
[45]
Meneses AC, Sayer C, Puton BMS. Production of clove oil nanoemulsion with rapid and enhanced antimicrobial activity against gram-positive and gram-negative bacteria. J Food Process Eng 2019; 42(6): 1-9.
[http://dx.doi.org/10.1111/jfpe.13209]
[46]
Srivastava M, Neupane YR, Kumar P. Nanoemulgel (NEG) of Ketoprofen with eugenol as oil phase for the treatment of ligature-induced experimental periodontitis in Wistar rats. Drug Deliv 2014; 23(7): 1-7.
[PMID: 25259423]
[47]
Panwar AS, Upadhyay N, Bairagi M. Emulgel, a review. Asian J of Pharm and Life Sci 2011; 1(3): 333-43.
[48]
Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev 2007; 59(7): 667-76.
[http://dx.doi.org/10.1016/j.addr.2007.05.006] [PMID: 17618704]
[49]
Ahmad J, Kohli K, Mir SR. Self-emulsifying nano carriers for improved oral bioavailability of lipophilic drugs. Rev Adv Sci Eng 2012; 1(2): 134-47.
[http://dx.doi.org/10.1166/rase.2012.1009]
[50]
Chouksey RK, Pandey HK, Maithil A. Nanoemulsion: a review. Invent Rapid Pharm Tech 2011; 2(1): 1-23.
[51]
Madhavi LS, Sridevi G. Role of polymers as gelling agents in the formulation of emulgels. Polymer Sci 2016; 2(1): 1-8.
[52]
Tanwar YS, Jain AK. Formulation and evaluation of topical diclofenac sodium gel using different gelling agent. Asian J of Pharm Res Health Care 2012; 4(1): 1-6.
[53]
Subramanian N, Ghosal SK, Moulik SP. Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion. Drug Dev Ind Pharm 2005; 31(4-5): 405-16.
[http://dx.doi.org/10.1080/03639040500214605] [PMID: 16093206]
[54]
Boukarim C, Abou Jaoude S, Bahnam R, Barada R, Kyriacos S. Preservatives in liquid pharmaceutical preparations. Drug Test Anal 2009; 1(3): 146-8.
[http://dx.doi.org/10.1002/dta.28] [PMID: 20355189]
[55]
Khullar R, Saini S, Seth N, Rana A. Emulgel: a surrogate approach for topically used hydrophobic drugs. Int J Pharma Bio Sci 2011; 1(3): 117-28.
[56]
Sagiv AE, Dikstein S, Ingber A. The efficiency of humectants as skin moisturizers in the presence of oil. Skin Res Technol 2001; 7(1): 32-5.
[http://dx.doi.org/10.1034/j.1600-0846.2001.007001032.x] [PMID: 11301638]
[57]
Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 2006; 123-126: 369-85.
[http://dx.doi.org/10.1016/j.cis.2006.05.014] [PMID: 16843424]
[58]
Rahman M, Akhter S, Ahmad J, Ahmad MZ, Beg S, Ahmad FJ. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy. Expert Opin Drug Deliv 2015; 12(4): 635-52.
[http://dx.doi.org/10.1517/17425247.2015.982088] [PMID: 25439967]
[59]
Malay NJ, Chandresh PP, Bhupendra GP. Nanoemulgel innovative approach for topical gel based formulation. ResRev Health Care Open Acc J 2018; 1(2): 18-23.
[60]
Kartiki SP, Ambekar AW, Chemate S. Formulation and characterization of etoricoxib and methyl salicylate loaded nanoemulgel. J Pharma Res 2018; 7(7): 143-8.
[61]
Basera K, Bhatt G, Kothiyal P. Nanoemulgel: a novel formulation approach for topical delivery of hydrophobic drugs. World J Pharm Sci 2015; 4(10): 1871-86.
[62]
Arora R, Aggarwal G, Harikumar SL. Nanoemulsion based hydrogel for enhanced transdermal delivery of Ketoprofen. Hindawi Pub Corp Adv Pharm 2014; 14(2): 1-12.
[http://dx.doi.org/10.1155/2014/468456]
[63]
Ahmad J, Mir SR, Kohli K. Quality by design approach for self nano-emulsifying system of paclitaxel. Sci Adv Mater 2014; 6: 1778-91.
[http://dx.doi.org/10.1166/sam.2014.1884]
[64]
Ahmad J, Amin S, Kohli K. Construction of Pseudoternary phase diagram and its evaluation: development of self-dispersible oral formulation. Int J Drug Deve Res 2013; 5(2): 1-7.
[65]
Lovelyn C, Attama AA. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol 2011; 2(05): 626-39.
[http://dx.doi.org/10.4236/jbnb.2011.225075]
[66]
Gurpreet K, Singh SK. Review of nanoemulsion formulation and characterization techniques. Indian J Pharm Sci 2018; 80(5): 781-9.
[http://dx.doi.org/10.4172/pharmaceutical-sciences.1000422]
[67]
Yilmaz E, Borchert HH. Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides. Eur J Pharm Biopharm 2005; 60(1): 91-8.
[http://dx.doi.org/10.1016/j.ejpb.2004.11.009] [PMID: 15848061]
[68]
Yang C, Shen Y, Wang J, Ouahab A, Zhang T, Tu J. Cationic polymer-based micro-emulgel with self-preserving ability for transdermal delivery of diclofenac sodium. Drug Deliv 2015; 22(6): 814-22.
[http://dx.doi.org/10.3109/10717544.2014.898111] [PMID: 24724988]
[69]
Dev A, Chodankar R, Shelke O. Emulgels: a novel topical drug delivery system. Pharm Biol Eval 2015; 2(4): 64-75.
[70]
Astuti KW, Wijayanti NPAD, Yustiantara PS. Anti-inflammatory activity of mangosteen (Garcinia mangostana Linn.) rind extract nanoemulgel and gel dosage forms. Biomed Pharmacol J 2019; 12(4): 1767-74.
[http://dx.doi.org/10.13005/bpj/1807]
[71]
Sengupta P, Chatterjee B. Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs. Int J Pharm 2017; 526(1-2): 353-65.
[http://dx.doi.org/10.1016/j.ijpharm.2017.04.068] [PMID: 28461261]
[72]
Drais HK, Hussein AH. Formulation characterization and evaluation of meloxicam nanoemulgel to be used topically. Iraqi J Pharm Sci 2017; 26(1): 9-16.
[73]
Dhawan B, Aggarwal G, Harikumar S. Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation. Int J Pharm Investig 2014; 4(2): 65-76.
[http://dx.doi.org/10.4103/2230-973X.133053] [PMID: 25006551]
[74]
Chiesa M, Garg J, Kang YT. Thermal conductivity and viscosity of water-in-oil nanoemulsions. Colloids Surf A Physicochem Eng Asp 2008; 326(1-2): 67-72.
[http://dx.doi.org/10.1016/j.colsurfa.2008.05.028]
[75]
Ambala R, Vemula SK. Formulation and characterization of ketoprofen emulgels. J Appl Pharm Sci 2015; 5(7): 112-7.
[76]
Kumar D, Singh J, Antil M. Emulgel-novel topical drug delivery system-a comprehensive review. Int J Pharm Sci Res 2016; 7(12): 4733-42.
[77]
Rahil MGB, Khushboo AB, Samir KS. Formulation and evaluation of topical nanoemulgel of adapalene. World J Pharm Sci 2015; 3(4): 1013-24.
[78]
Kaur G. TPGS Loaded topical nanoemulgel of mefenamic acid for the treatment of rheumatoid arthritis. Int J Pharm Res 2019; 15(1): 64-07.
[79]
Bhavesh SR, Shah CN. Nanoemulgel: A comprehensive review on the recent advances intopical drug delivery. Pharma Sci Monitor 2016; 7(2): 346-55.
[80]
Lakshmana PS, Sharvanan SP, Aravindan S. Nanoemulgel for transdermal delivery of cyclobenzaprine hydrochloride: design, characterization and in-vitro studies. Nov Appro Drug Des Dev 2017; 1(5): 1-7.
[81]
Samia O, Hanan R, Kamal T. Carbamazepine mucoadhesive nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa. Drug Deliv 2012; 19(1): 58-67.
[http://dx.doi.org/10.3109/10717544.2011.644349] [PMID: 22191715]
[82]
Rambharose S, Kalhapure RS, Govender T. Nanoemulgel using a bicephalous heterolipid as a novel approach to enhance transdermal permeation of tenofovir. Colloids Surf B Biointerfaces 2017; 154(1): 221-7.
[http://dx.doi.org/10.1016/j.colsurfb.2017.03.040] [PMID: 28343120]
[83]
Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci 2004; 108-109: 303-18.
[http://dx.doi.org/10.1016/j.cis.2003.10.023] [PMID: 15072948]
[84]
Salem HF, Kharshoum RM, Abou-Taleb HA, Naguib DM. Nanosized nasal emulgel of resveratrol: preparation, optimization, in vitro evaluation and in vivo pharmacokinetic study. Drug Dev Ind Pharm 2019; 45(10): 1624-34.
[http://dx.doi.org/10.1080/03639045.2019.1648500] [PMID: 31353967]
[85]
Morsy MA, Abdel-Latif RG, Nair AB, et al. Preparation and evaluation of Atorvastatin-loaded nanoemulgel on wound-healing efficacy. Pharmaceutics 2019; 11(11): 1-15.
[http://dx.doi.org/10.3390/pharmaceutics11110609] [PMID: 31766305]
[86]
Hussain A, Samad A, Singh SK. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv 2014; 1-16.
[PMID: 25013957]
[87]
Marwah H, Garg T, Goyal AK, Rath G. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv 2016; 23(2): 564-78.
[http://dx.doi.org/10.3109/10717544.2014.935532] [PMID: 25006687]
[88]
Zhang Z, Tsai PC, Ramezanli T, Michniak-Kohn BB. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013; 5(3): 205-18.
[http://dx.doi.org/10.1002/wnan.1211] [PMID: 23386536]
[89]
Goyal R, Macri LK, Kaplan HM, Kohn J. Nanoparticles and nanofibers for topical drug delivery. J Control Release 2016; 240: 77-92.
[http://dx.doi.org/10.1016/j.jconrel.2015.10.049] [PMID: 26518723]
[90]
Habif TP. Clinical dermatology. Netherlands: Elsevier 2006; pp. 1-1086.
[91]
Hamblin M, Avci P, Prow T. Nanoscience in dermatology. Netherlands: Elsevier Inc 2016; pp. 1-402.
[92]
Esposito S, Bassetti M, Concia E. Diagnosis and management of skin and soft-tissue infections (SSTI) A literature review and consensus statement: an update. J Chemother 2017; 1973-9478.
[93]
Mishra RK, Soni GC, Mishra RP. Nanoemulsion: a review article. World J Pharm Sci 2014; 3(9): 258-72.
[94]
Somagoni J, Boakye CHA, Godugu C, et al. Nanomiemgel-a novel drug delivery system for topical application-in vitro and in vivo evaluation. PLoS One 2014; 9(12): e115952.
[http://dx.doi.org/10.1371/journal.pone.0115952] [PMID: 25546392]
[95]
Debnath SS, Kumar GV. Nanoemulsion-a method to improve the solubility of lipophilic drugs. Pharmanest AIJAPS 2011; 2(3): 72-83.
[96]
Wani RR, Patil MP, Dhurjad P, Chaudhari CA, Kshirasagar SJ. Microemulsion based gel: a novel approach in the delivery of hydrophobic drugs. IJPRS 2015; 4(2): 397-10.
[97]
Ansari SH, Islam F, Sameem M. Influence of nanotechnology on herbal drugs: a Review. J Adv Pharm Technol Res 2012; 3(3): 142-6.
[http://dx.doi.org/10.4103/2231-4040.101006] [PMID: 23057000]
[98]
Aruna MS, Sravani A, Resshma V. Formulation and evaluation of herbal acne gel. World J Pharm Res 2015; 4(5): 2324-30.
[99]
Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases 2012. 9 (7): 783-804.
[http://dx.doi.org/10.1517/17425247.2012.686490]
[100]
Sultana F, Imran-Ul-Haque M, Arafat M, Sharmin S. An overview of nanogel delivery system. J Appl Pharm Sci 2013; 3: S95-S105.
[101]
Viswanathan B, Salim MI, Subramani A, Sruthi JA, Shabeer TK. Historic review on modern herbal nanogel formulation and delivery methods. Int J Pharm Pharm Sci 2018; 10(10): 1-10.
[102]
Shilpi A, Pradip KK, Gaurav A. Semi-herbal nanogel of clindamycin phosphate and aloe vera: formulation and evaluation. Mod Appl Bioequiv Availab 2017; 2(5): 555596.
[103]
Kumar A, Nayak A, Ghatuary SK. Design, Optimization and characterization of a transferosomal gel of Acyclovir for effective treatment of Herpes zoster. J Drug Deliv Ther 2019; 9(4-A): 712-21.
[104]
Paliwal S, Kaur G, Arya KK. Formulation and characterization of topical nanoemulgel of terbinafine. Universal J of Pharmac Res 2018; 3(6): 28-34.
[105]
Aithal GC, Nayak UY, Mehta C, et al. Localized in situ nanoemulgel drug delivery system of Quercetin for Periodontitis: development and computational simulations. Molecules 2018; 23(6): 1-15.
[http://dx.doi.org/10.3390/molecules23061363] [PMID: 29882751]
[106]
Mahtab A, Anwar M, Mallick N, Naz Z, Jain GK, Ahmad FJ. Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis. AAPS PharmSciTech 2016; 17(6): 1477-90.
[http://dx.doi.org/10.1208/s12249-016-0488-0] [PMID: 26857516]
[107]
Suminar MM, Jufri M. Physical stability and antioxidant activity assay of a nanoemulsion gel formulation containing tocotrienol. Int J App Pharm 2017; 9(1): 1-4.
[http://dx.doi.org/10.22159/ijap.2017.v9s1.74_81]
[108]
Kaur A, Sharma S, Singh M. Formulation and evaluation of nano-emulsion gel of Amphotericin B for treatment of skin infections. Int Res J Pharm 2018; 9(7): 99-02.
[http://dx.doi.org/10.7897/2230-8407.097132]
[109]
Mao Y, Chen X, Xu B, et al. Eprinomectin nanoemulgel for transdermal delivery against endoparasites and ectoparasites: preparation, in vitro and in vivo evaluation. Drug Deliv 2019; 26(1): 1104-14.
[http://dx.doi.org/10.1080/10717544.2019.1682720] [PMID: 31735104]
[110]
Syamala U. Development & optimization of Allyl amine antifungal nanoemulgel using 23 factorial designs: for the treatment of Tineapedis. Eur Sci J 2013; 4: 595-05.
[111]
Eid AM, El-Enshasy HA, Aziz R. Preparation, characterization and anti-inflammatory activity of Swietenia macrophylla nanoemulgel. J Nanomed Nanotechnol 2014; 5(2): 1-10.
[http://dx.doi.org/10.4172/2157-7439.1000190]
[112]
Mulia K, Ramadhan RMA, Krisanti EA. Formulation and characterization of nanoemulgel mangosteen extract in virgin coconut oil for topical formulation. MATEC Web Conf. 2018; 156: 1-7.
[http://dx.doi.org/10.1051/matecconf/201815601013]
[113]
Gadkari PN, Patil PB, Saudagar RB. Formulation, development and evaluation of topical nanoemulgel of tolnaftate. J Drug Deliv Ther 2019; 9(2-s): 208-13.
[114]
Taglietti M, Hawkins CN, Rao J. Novel topical drug delivery systems and their potential use in acne vulgaris. Skin Therapy Lett 2008; 13(5): 6-8.
[PMID: 18648713]
[115]
Aman RM, Abu Hashim II, Meshali MM. Novel clove essential oil nanoemulgel tailored by taguchi’s model and scaffold-based nanofibers: phytopharmaceuticals with promising potential as Cyclooxygenase-2 inhibitors in external inflammation. Int J Nanomedicine 2020; 15: 2171-95.
[http://dx.doi.org/10.2147/IJN.S246601] [PMID: 32280213]
[116]
Baskar V, Salim MI, Ali J. Historic review on modern herbal nanogel formulation and delivery methods. Int J Pharm Pharm Sci 2018; 10(10): 1-10.
[http://dx.doi.org/10.22159/ijpps.2018v10i10.23071]
[117]
Algahtani MS, Ahmad MZ, Ahmad J. Nanoemulgel for improved topical delivery of retinyl palmitate: formulation design and stability evaluation. Nanomaterials (Basel) 2020; 10(5): 1-18.
[http://dx.doi.org/10.3390/nano10050848] [PMID: 32353979]
[118]
Choudhury H, Gorain B, Pandey M, et al. Recent update on nanoemulgel as topical drug delivery system. J Pharma Sci 2017; 106(7): 1736-51.
[119]
Algahtani MS, Ahmad MZ, Nourein IH, Ahmad J. Co-delivery of imiquimod and curcumin by nanoemugel for improved topical delivery and reduced psoriasis-like skin lesions. Biomolecules 2020; 10(7): 1-18.
[http://dx.doi.org/10.3390/biom10070968] [PMID: 32605030]
[120]
Eid AM, Istateyeh I, Salhi N, Istateyeh T. Antibacterial activity of fusidic acid and sodium fusidate nanoparticles incorporated in pine oil nanoemulgel. Int J Nanomedicine 2019; 14: 9411-21.
[http://dx.doi.org/10.2147/IJN.S229557] [PMID: 31819440]
[121]
Vartak R, Menon S, Patki M, Billack B, Patel K. Ebselen nanoemulgel for the treatment of topical fungal infection. Eur J Pharm Sci 2020; 148: 105323.
[http://dx.doi.org/10.1016/j.ejps.2020.105323] [PMID: 32259677]
[122]
Md S, Alhakamy NA, Aldawsari HM. Improved analgesic and anti-inflammatory effect of diclofenac sodium by topical nanoemulgel: formulation development-in-vitro and in-vivo studies. J Chem 2020; 1-10.
[http://dx.doi.org/10.1155/2020/4071818]
[123]
Choudhury H, Gorain B, Pandey M, et al. Recent update on nanoemulgel as topical drug delivery system. J Pharm Sci 2017; 106(7): 1736-51.
[http://dx.doi.org/10.1016/j.xphs.2017.03.042] [PMID: 28412398]
[124]
Ahmed RH, Mustafa DE. Green synthesis of silver nanoparticles mediated by traditionally used medicinal plants in Sudan. Int Nano Lett 2020; 10: 1-14.
[http://dx.doi.org/10.1007/s40089-019-00291-9]
[125]
Ashraf H, Anjum T, Riaz S, Naseem S. Microwave-assisted green synthesis and characterization of silver nanoparticles using Melia azedarach for the management of fusarium wilt in tomato. Front Microbiol 2020; 11: 238.
[http://dx.doi.org/10.3389/fmicb.2020.00238] [PMID: 32210928]
[126]
Prabu SL, Umamaheswari A, Rajakumar S, Bhuvaneswari PL, Muthupetchi S. Development and evaluation of gel incorporated with synthesized silver nanoparticle from Ocimum gratissimum for the treatment of acne vulgaris. Amer J of Advan Drug Deliv 2017; 5: 107-17.
[http://dx.doi.org/10.21767/2321-547X.1000018]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy